Regulation of apoptosis by alternative pre-mRNA splicing.

Apoptosis, a phenomenon that allows the regulated destruction and disposal of damaged or unwanted cells, is common to many cellular processes in multicellular organisms. In humans more than 200 proteins are involved in apoptosis, many of which are dysregulated or defective in human diseases including cancer. A large number of apoptotic factors are regulated via alternative splicing, a process that allows for the production of discrete protein isoforms with often distinct functions from a common mRNA precursor. The abundance of apoptosis genes that are alternatively spliced and the often antagonistic roles of the generated protein isoforms strongly imply that alternative splicing is a crucial mechanism for regulating life and death decisions. Importantly, modulation of isoform production of cell death proteins via pharmaceutical manipulation of alternative splicing may open up new therapeutic avenues for the treatment of disease.

[1]  K. Schulze-Osthoff,et al.  Non-apoptotic functions of caspases in cellular proliferation and differentiation. , 2003, Biochemical pharmacology.

[2]  M. Beato,et al.  Promoter Choice Influences Alternative Splicing and Determines the Balance of Isoforms Expressed from the Mousebcl-X Gene* , 2001, The Journal of Biological Chemistry.

[3]  M. P. Holloway,et al.  Survivin splice variants regulate the balance between proliferation and cell death , 2005, Oncogene.

[4]  C. Thompson,et al.  bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death , 1993, Cell.

[5]  A. Godzik,et al.  The Domains of Apoptosis: A Genomics Perspective , 2004, Science's STKE.

[6]  Y. Rao,et al.  Regulation of Ich-1 pre-mRNA alternative splicing and apoptosis by mammalian splicing factors. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[7]  R. Testi,et al.  Fas/Apo-1 (CD95) receptor lacking the intracytoplasmic signaling domain protects tumor cells from Fas-mediated apoptosis. , 1996, Journal of immunology.

[8]  J. Côté,et al.  Polypyrimidine Track-binding Protein Binding Downstream of Caspase-2 Alternative Exon 9 Represses Its Inclusion* , 2001, The Journal of Biological Chemistry.

[9]  H. Lodish,et al.  Tumor Necrosis Factor Receptor (TNFR)-associated Factor 2A (TRAF2A), a TRAF2 Splice Variant with an Extended RING Finger Domain That Inhibits TNFR2-mediated NF-κB Activation* , 1998, The Journal of Biological Chemistry.

[10]  Ingo Schmitz,et al.  Differential Modulation of Apoptosis Sensitivity in CD95 Type I and Type II Cells* , 1999, The Journal of Biological Chemistry.

[11]  Xin Lu,et al.  Live or let die: the cell's response to p53 , 2002, Nature Reviews Cancer.

[12]  D. Reinberg,et al.  ASAP, a Novel Protein Complex Involved in RNA Processing and Apoptosis , 2003, Molecular and Cellular Biology.

[13]  P. Loyer,et al.  The RNP protein, RNPS1, associates with specific isoforms of the p34cdc2-related PITSLRE protein kinase in vivo. , 1998, Journal of cell science.

[14]  P. Krammer,et al.  Resistance of Short Term Activated T Cells to CD95-Mediated Apoptosis Correlates with De Novo Protein Synthesis of c-FLIPshort1 , 2004, The Journal of Immunology.

[15]  G. Melino,et al.  p73: Friend or foe in tumorigenesis , 2002, Nature Reviews Cancer.

[16]  J. Côté,et al.  Caspase-2 pre-mRNA alternative splicing: Identification of an intronic element containing a decoy 3' acceptor site. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[17]  M. Garcia-Blanco,et al.  Co-transcriptional splicing of pre-messenger RNAs: considerations for the mechanism of alternative splicing. , 2001, Gene.

[18]  S. Edwards,et al.  Alternative splicing of Bcl-2-related genes: functional consequences and potential therapeutic applications , 2004, Cellular and Molecular Life Sciences CMLS.

[19]  Shelly C. Lu,et al.  S‐adenosylmethionine and its metabolite induce apoptosis in HepG2 cells: Role of protein phosphatase 1 and Bcl‐xS , 2004, Hepatology.

[20]  E V Koonin,et al.  Apoptotic molecular machinery: vastly increased complexity in vertebrates revealed by genome comparisons. , 2001, Science.

[21]  W. Earnshaw,et al.  Differential localization of ICAD-L and ICAD-S in cells due to removal of a C-terminal NLS from ICAD-L by alternative splicing. , 2000, Experimental cell research.

[22]  Y. Hannun,et al.  FAS Activation Induces Dephosphorylation of SR Proteins , 2001, The Journal of Biological Chemistry.

[23]  M. Bourgeade,et al.  B Cell Receptor-Mediated Apoptosis of Human Lymphocytes Is Associated with a New Regulatory Pathway of Bim Isoform Expression1 , 2004, The Journal of Immunology.

[24]  D. Altieri.  Validating survivin as a cancer therapeutic target , 2003, Nature Reviews Cancer.

[25]  Jerry M. Adams,et al.  Ways of dying: multiple pathways to apoptosis. , 2003, Genes & development.

[26]  G. Matlashewski,et al.  Regulation of Human p53 Activity and Cell Localization by Alternative Splicing , 2004, Molecular and Cellular Biology.

[27]  J. Valcárcel,et al.  The splicing regulator TIA‐1 interacts with U1‐C to promote U1 snRNP recruitment to 5′ splice sites , 2002, The EMBO journal.

[28]  M. Saarma,et al.  Neuron-specific Bcl-2 Homology 3 Domain-only Splice Variant of Bak Is Anti-apoptotic in Neurons, but Pro-apoptotic in Non-neuronal Cells* , 2001, The Journal of Biological Chemistry.

[29]  J. Bell,et al.  LARD: a new lymphoid-specific death domain containing receptor regulated by alternative pre-mRNA splicing. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[30]  J. Gottesfeld,et al.  Cyclin L Is an RS Domain Protein Involved in Pre-mRNA Splicing* , 2002, The Journal of Biological Chemistry.

[31]  S H Kaufmann,et al.  Mammalian caspases: structure, activation, substrates, and functions during apoptosis. , 1999, Annual review of biochemistry.

[32]  G. Núñez,et al.  Expression and Functional Analysis of Apaf-1 Isoforms , 2000, The Journal of Biological Chemistry.

[33]  H. Horvitz,et al.  The genetics of programmed cell death in the nematode Caenorhabditis elegans. , 1994, Cold Spring Harbor symposia on quantitative biology.

[34]  A. Mayeda,et al.  CDK11 Complexes Promote Pre-mRNA Splicing* , 2003, The Journal of Biological Chemistry.

[35]  J. Tschopp,et al.  Regulation of Interleukin-1- and Lipopolysaccharide-Induced NF-κB Activation by Alternative Splicing of MyD88 , 2002, Current Biology.

[36]  C. Suschek,et al.  Differential subcellular localization of functionally divergent survivin splice variants , 2002, Cell Death and Differentiation.

[37]  P. Krammer,et al.  FLICE-Inhibitory Proteins: Regulators of Death Receptor-Mediated Apoptosis , 2001, Molecular and Cellular Biology.

[38]  J. Stévenin,et al.  TIA-1 and TIAR Activate Splicing of Alternative Exons with Weak 5′ Splice Sites followed by a U-rich Stretch on Their Own Pre-mRNAs* , 2001, The Journal of Biological Chemistry.

[39]  S. Dower,et al.  Three Novel Bid Proteins Generated by Alternative Splicing of the Human Bid Gene* , 2004, Journal of Biological Chemistry.

[40]  T. Cooper,et al.  Pre-mRNA splicing and human disease. , 2003, Genes & development.

[41]  Shizuo Akira,et al.  Toll-like Receptor Signaling* , 2003, Journal of Biological Chemistry.

[42]  H. Lou,et al.  U1 snRNP-Dependent Function of TIAR in the Regulation of Alternative RNA Processing of the Human Calcitonin/CGRP Pre-mRNA , 2003, Molecular and Cellular Biology.

[43]  D. Cooper,et al.  The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: Causes and consequences , 1992, Human Genetics.

[44]  K. Schulze-Osthoff,et al.  The role of caspases in development, immunity, and apoptotic signal transduction: lessons from knockout mice. , 1999, Immunity.

[45]  B. Graveley.  Sorting out the complexity of SR protein functions. , 2000, RNA.

[46]  John Calvin Reed,et al.  Immunohistochemical analysis of in vivo patterns of Bcl-X expression. , 1994, Cancer research.

[47]  Jane Y. Wu,et al.  Alternative pre-mRNA splicing and regulation of programmed cell death. , 2003, Progress in molecular and subcellular biology.

[48]  G. Pruijn,et al.  The fate of U1 snRNP during anti-Fas induced apoptosis: specific cleavage of the U1 snRNA molecule , 2000, Cell Death and Differentiation.

[49]  D. K. Miller,et al.  Specific cleavage of the 70-kDa protein component of the U1 small nuclear ribonucleoprotein is a characteristic biochemical feature of apoptotic cell death. , 1994, The Journal of biological chemistry.

[50]  D. Green,et al.  The Pathophysiology of Mitochondrial Cell Death , 2004, Science.

[51]  C. Guthrie,et al.  Mechanical Devices of the Spliceosome: Motors, Clocks, Springs, and Things , 1998, Cell.

[52]  Steven P. Gygi,et al.  Comprehensive proteomic analysis of the human spliceosome , 2002, Nature.

[53]  J Vandekerckhove,et al.  Nuclear relocalization of the pre-mRNA splicing factor PSF during apoptosis involves hyperphosphorylation, masking of antigenic epitopes, and changes in protein interactions. , 2001, Molecular biology of the cell.

[54]  F. Li,et al.  Role of survivin and its splice variants in tumorigenesis , 2004, British Journal of Cancer.

[55]  C. Chalfant,et al.  Identification of Two RNA cis-Elements That Function to Regulate the 5′ Splice Site Selection of Bcl-x Pre-mRNA in Response to Ceramide* , 2004, Journal of Biological Chemistry.

[56]  J. E. Mermoud,et al.  Regulation of mammalian spliceosome assembly by a protein phosphorylation mechanism. , 1994, The EMBO journal.

[57]  A. Porter,et al.  Molecular Cloning and Characterization of Two Novel Pro-apoptotic Isoforms of Caspase-10* , 1999, The Journal of Biological Chemistry.

[58]  J. Valcárcel,et al.  Molecular mechanisms of gene expression regulation by the apoptosis-promoting protein TIA-1 , 2001, Apoptosis.

[59]  Bosiljka Tasic,et al.  Alternative pre-mRNA splicing and proteome expansion in metazoans , 2002, Nature.

[60]  P. Anderson,et al.  Human Autoimmune Sera as Molecular Probes for the Identification of an Autoantigen Kinase Signaling Pathway , 2002, The Journal of experimental medicine.

[61]  K. Schulze-Osthoff,et al.  Many cuts to ruin: a comprehensive update of caspase substrates , 2003, Cell Death and Differentiation.

[62]  D. Seol,et al.  A Caspase-9 Variant Missing the Catalytic Site Is an Endogenous Inhibitor of Apoptosis* , 1999, The Journal of Biological Chemistry.

[63]  H. Horvitz,et al.  An Alternatively Spliced C. elegans ced-4 RNA Encodes a Novel Cell Death Inhibitor , 1996, Cell.

[64]  T. Misteli,et al.  Serine/threonine phosphatase 1 modulates the subnuclear distribution of pre-mRNA splicing factors. , 1996, Molecular biology of the cell.

[65]  Nan Li,et al.  Cyclin L2, a Novel RNA Polymerase II-associated Cyclin, Is Involved in Pre-mRNA Splicing and Induces Apoptosis of Human Hepatocellular Carcinoma Cells* , 2004, Journal of Biological Chemistry.

[66]  Y. Hannun,et al.  De Novo Ceramide Regulates the Alternative Splicing of Caspase 9 and Bcl-x in A549 Lung Adenocarcinoma Cells , 2002, The Journal of Biological Chemistry.

[67]  A. Strasser,et al.  Bim: a novel member of the Bcl‐2 family that promotes apoptosis , 1998, The EMBO journal.

[68]  J. Manley,et al.  SR proteins and splicing control. , 1996, Genes & development.

[69]  D. Hancock,et al.  Identification of Novel Isoforms of the BH3 Domain Protein Bim Which Directly Activate Bax To Trigger Apoptosis , 2002, Molecular and Cellular Biology.

[70]  C. Riccardi,et al.  Cloning and expression of a short Fas ligand: A new alternatively spliced product of the mouse Fas ligand gene. , 1999, Blood.

[71]  L. Cantley,et al.  Use of RNA Interference-mediated Gene Silencing and Adenoviral Overexpression to Elucidate the Roles of AKT/Protein Kinase B Isoforms in Insulin Actions* , 2003, Journal of Biological Chemistry.

[72]  C. Rudin,et al.  Apoptosis and disease: regulation and clinical relevance of programmed cell death. , 1997, Annual review of medicine.

[73]  N. Imamoto,et al.  Acinus is a caspase-3-activated protein required for apoptotic chromatin condensation , 1999, Nature.

[74]  M. Beato,et al.  Steroid Hormones Induce bcl-X Gene Expression through Direct Activation of Distal Promoter P4* , 2004, Journal of Biological Chemistry.

[75]  D. Ferrari,et al.  Apoptosis signaling by death receptors. , 1998, European journal of biochemistry.

[76]  S. Elledge,et al.  Fas-activated serine/threonine kinase (FAST) phosphorylates TIA-1 during Fas-mediated apoptosis , 1995, The Journal of experimental medicine.

[77]  Shizuo Akira,et al.  Toll-like receptor signalling , 2004, Nature Reviews Immunology.

[78]  R. Kole,et al.  Therapeutic potential of antisense oligonucleotides as modulators of alternative splicing. , 2003, The Journal of clinical investigation.

[79]  Pierre Hainaut,et al.  p53 protein variants: structural and functional similarities with p63 and p73 isoforms , 2004, Oncogene.

[80]  G. Fiucci,et al.  Three functional soluble forms of the human apoptosis-inducing Fas molecule are produced by alternative splicing. , 1995, Journal of immunology.

[81]  P. Anderson,et al.  Association of Phosphorylated Serine/Arginine (SR) Splicing Factors With The U1–Small Ribonucleoprotein (snRNP) Autoantigen Complex Accompanies Apoptotic Cell Death , 1998, The Journal of experimental medicine.

[82]  J. Comella,et al.  Characterization of splice variants of human caspase‐activated DNase with CIDE‐N structure and function , 2004, FEBS letters.

[83]  O. Janssen,et al.  CD95 ligand - death factor and costimulatory molecule? , 2003, Cell Death and Differentiation.

[84]  Christopher J. Lee,et al.  Alternative splicing in the human, mouse and rat genomes is associated with an increased frequency of exon creation and/or loss , 2003, Nature Genetics.

[85]  Matthew J. Brauer,et al.  Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. , 1994, Science.

[86]  P. Krammer,et al.  c-FLIPR, a New Regulator of Death Receptor-induced Apoptosis* , 2005, Journal of Biological Chemistry.

[87]  I. N. Crispe,et al.  A naturally occurring soluble isoform of murine Fas generated by alternative splicing , 1995, The Journal of experimental medicine.

[88]  D. Brow,et al.  Allosteric cascade of spliceosome activation. , 2002, Annual review of genetics.

[89]  Brenton R Graveley,et al.  Exon-specific RNAi: a tool for dissecting the functional relevance of alternative splicing. , 2002, RNA.

[90]  L. Bracco,et al.  The relevance of alternative RNA splicing to pharmacogenomics. , 2003, Trends in biotechnology.

[91]  Xiaolu Yang,et al.  c‐FLIPL is a dual function regulator for caspase‐8 activation and CD95‐mediated apoptosis , 2002, The EMBO journal.

[92]  J. Wyatt,et al.  Induction of endogenous Bcl-xS through the control of Bcl-x pre-mRNA splicing by antisense oligonucleotides , 1999, Nature Biotechnology.

[93]  Ying Jin,et al.  Smac3, a Novel Smac/DIABLO Splicing Variant, Attenuates the Stability and Apoptosis-inhibiting Activity of X-linked Inhibitor of Apoptosis Protein* , 2003, Journal of Biological Chemistry.

[94]  Sherif Abou Elela,et al.  Reprogramming Alternative Pre-messenger RNA Splicing through the Use of Protein-binding Antisense Oligonucleotides* , 2003, Journal of Biological Chemistry.

[95]  A. Strasser,et al.  The proapoptotic activity of the Bcl-2 family member Bim is regulated by interaction with the dynein motor complex. , 1999, Molecular cell.

[96]  L. Wang,et al.  Ich-1, an Ice/ced-3-related gene, encodes both positive and negative regulators of programmed cell death , 1994, Cell.

[97]  J. Tschopp,et al.  The Long Form of FLIP Is an Activator of Caspase-8 at the Fas Death-inducing Signaling Complex* , 2002, The Journal of Biological Chemistry.

[98]  S. Lederman,et al.  TRAF-3 mRNA splice-deletion variants encode isoforms that induce NF-kappaB activation. , 1999, Molecular immunology.

[99]  K. Burns,et al.  Inhibition of Interleukin 1 Receptor/Toll-like Receptor Signaling through the Alternatively Spliced, Short Form of MyD88 Is Due to Its Failure to Recruit IRAK-4 , 2003, The Journal of experimental medicine.

[100]  D. Black.  Mechanisms of alternative pre-messenger RNA splicing. , 2003, Annual review of biochemistry.

[101]  B. Aggarwal.  Signalling pathways of the TNF superfamily: a double-edged sword , 2003, Nature Reviews Immunology.